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One mouse ≠ one experiment
In the past several years, the editors of 
the  JEM  have  noticed  a  troubling 
trend.  Authors  are  increasingly  sub-
mitting data for publication that derive 
from  a  single  experiment.  Whatever 
the driving force behind this trend, it 
is  a  worrying  one.  The  independent 
verification of experimental data is es-
sential  to  demonstrate  the  reproduc-
ibility of a result and is a fundamental 
tenet  of  scientific  experimentation. 
Without independent replication, data 
lose  rigor  and  publications  lose 
credibility.
At  the  heart  of  this  issue  is  the 
definition  of  an  independent  experi-
ment. The editors of the JEM define 
a single, independent experiment as 
one in which experimental and con-
trol  groups  (comprising  individual 
mice, culture wells, etc.) are tested 
contemporaneously to answer a spe-
cific question. Each independent ex-
periment must be repeated a sufficient 
number of times to demonstrate the 
reproducibility of the data.
Authors have offered various justifi-
cations for submitting data from a single 
experiment. One argument that has re-
peatedly cropped up, particularly in the 
context of experiments involving bone 
marrow  chimeras,  is  that  one  mouse 
equals  one  experiment.  According  to 
this reasoning, each mouse generates a 
new  immune  system  from  the  trans-
ferred bone marrow, and the inevitable 
variability  among  individual  animals 
renders each an experiment unto itself. 
What  this  argument  fails  to  consider, 
however, is the fact that experiments 
performed on any given day could pro-
duce erroneous results for several rea-
sons.  For  example,  the  bone  marrow 
cells  transferred  into  recipient  mice 
could be contaminated. No matter how 
many chimeric mice are made or how 
many  controls  are  performed,  if  they 
are  tested  contemporaneously,  they 
constitute a single experiment.
Another  frequent  justification  for 
single  experiments  is  that  a  sufficient 
number of mice were included in each 
experimental group to generate a statis-
tically meaningful result. Although this 
is a laudable practice that should apply 
to all experiments, it has no bearing on 
the issue of experimental reproducibil-
ity.  Others  simply  argue  that  certain 
experiments  are  too  time  consuming 
and/or  expensive  to  justify  repetition 
(on occasion authors have even claimed 
that  repeated  experiments  would  be 
prohibited by institutional animal care 
and use committees).
As outlined in our revised Instruc-
tions to Authors, all figure legends must 
specify the number of times each ex-
periment was independently performed, 
as well as the number of animals or rep-
licates in each experimental group. Al-
though  we  are  reluctant  to  dictate  a 
specific number of independent experi-
ments that must be conducted in any 
given  case,  data  used  to  support  any 
conclusion of the study must be per-
formed more than once and must be 
repeated a sufficient number of times to 
demonstrate reproducibility.
The  JEM  continues  to  encourage 
submission of studies involving humans 
and nonhuman primates, and we under-
stand that these studies cannot be readily 
repeated in their entirety. Vaccine studies, 
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Scientific journals, like cars, re-
quire periodic tune-ups to keep 
them running smoothly. Effective 
immediately, several changes to the 
JEM publication policies will take 
effect. Our aim is to address policy 
issues that have arisen over the 
past several years and, more 
broadly, to maintain the quality 
and integrity of the research we 
publish. The upcoming changes to 
JEM policies and the impetus 
behind them are outlined here.
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for example, typically follow groups of 
patients or primates longitudinally, com-
paring various parameters of the immune 
response relative to a control group. For 
these studies, it is sufficient to state the 
number of individuals in each group.
Length limits and referencing
The JEM will continue to publish man-
uscripts  in  two  formats—full  Articles 
and Brief Definitive Reports (BDRs). 
The length limits for both formats will 
increase  modestly  to  accommodate  a 
change in referencing style (see below). 
Full articles may now include 10 display 
items and 44,000 characters (excluding 
Materials and methods and References), 
which should provide ample space to 
report  a  fully  developed  story.  Our 
BDR format is tailored to exciting new 
observations  that  are  less  extensively 
explored  but  have  the  potential  to 
prompt new lines of investigation. The 
length limit for BDRs will increase to 
22,000 characters, and we will now al-
low the inclusion of 6 display items and 
40 references.
A more substantial change to JEM’s 
current format policies is the introduc-
tion of a limit on the number of supple-
mental items that can accompany each 
manuscript. Although we are aware of 
the need for supplemental data—which 
are often added in response to referees’ 
concerns—the volume of added mate-
rial has become excessive to the detri-
ment  of  readability.  The  inclusion  of 
supplemental data should be judicious, 
and only those data that are directly rel-
evant to the message of the paper should 
be included. As such, we will now limit 
supplemental materials to four items for 
BDRs and eight items for Articles (ex-
cluding  videos).  In  addition,  supple-
mental  text  and  references  must  be 
limited to figure legends and materials 
and  methods  that  were  used  only  to 
generate supplemental data. All methods 
used to generate data in the main body 
of the paper must be described in detail 
in the Materials and methods section.
Another big change is in our refer-
encing format. The JEM has historically 
used numbered referencing, in which 
citations  are  simply  numbered  in  the 
order  they  appear  in  the  manuscript. 
However our sister journals, the Journal 
of  Cell  Biology  and  Journal  of  General 
Physiology use Harvard style, in which 
references are cited parenthetically by 
first author and year of publication, and 
the  reference  section  is  organized  al-
phabetically.  The  JEM  will  now  use 
Harvard  style  references.  This  format 
provides  valuable  information  to  the 
reader without requiring periodic flip-
ping to the reference list. This change 
will also facilitate the manuscript pro-
duction process and help to eliminate 
errors in reference numbering that oc-
casionally  occur  when  citations  are 
added at the proof stage. We feel that 
the increased length allowance will help 
to offset the change to Harvard style.
The coining contagion
The  immunology  lexicon—perhaps 
more so than that of any other biologi-
cal science—is rife with acronyms and 
jargon. Amid the ever-increasing num-
ber of interleukins and CD molecules 
comes the regular introduction of new 
molecules, cell subsets, and pathways. 
Where there were once only a hand-
ful of immune cell subsets, for example, 
there  are  now  a  bevy  of  varieties  of 
helper T (Th) cells, regulatory T cells, B 
cells, dendritic cells, and macrophages.
Newly coined names often reflect a 
previously  unappreciated  function  or 
product of a particular cell subset in a 
particular  environment.  But  although 
the  name  may  be  appropriate  at  the 
time, it often becomes obsolete as more 
functions and products are attributed to 
that entity. Some authors have argued 
that  coining  a  catchy  new  name  will 
make their research more memorable. 
But strong data stand on their own, and 
once-apt names can ultimately become 
more  of  an  impediment  to  scientific 
clarity than a help.
If  the  name-coining  contagion  goes 
unchecked, we run the risk of clogging 
our vocabulary with superfluous jargon, 
rendering it impenetrable to nonimmu-
nologists (much less to the general public). 
To  avoid  contributing  to  this  glut,  the 
JEM discourages authors from introducing 
new terminology unless there is a compel-
ling scientific justification for doing so. If, 
for example, you identify a new protein 
with a chemical structure and function 
unlike any existing class of protein, it’s 
yours to name. But if the new protein 
resembles an existing protein or family, 
the name should reflect this relation-
ship. The same rule applies to cell sub-
sets. For example, just because CD4
+ 
Th cells can secrete interleukin-9 under 
certain circumstances, are we justified 
in branding those cells “Th9”?
Thus,  in  the  interest  of  scientific 
clarity, the JEM will now require a sci-
entific  justification  whenever  a  new 
name or term is proposed.
These amendments to the JEM edi-
torial  policies  are  intended  to  help 
maintain the high quality of science that 
we publish, and to better serve the sci-
entific community. As always, we wel-
come  any  suggestions  from  the 
community for how we can best serve 
your needs as authors, reviewers, and 
readers.